Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
83.72
-0.18 (-0.21%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $8.83 billion as of July 23, 2026. Its market cap has increased by 204.46% in one year.
Market Cap
8.83B
Enterprise Value
7.58B
1-Year Change
204.46%
Ranking
Category
Stock Price
$83.72
ChartMarket Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $539.40M to $8.83B, an increase of 1,536.53%. That is a compound annual growth rate of 41.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 8.83B | 99.84% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.70M | -27.03% |
| Dec 31, 2021 | 1.35B | 190.53% |
| Dec 31, 2020 | 464.50M | -23.56% |
| Dec 31, 2019 | 607.70M | -15.70% |
| Dec 31, 2018 | 720.90M | 33.65% |
| Jul 18, 2018 | 539.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 9.99B |
| Corcept Therapeutics | 9.83B |
| Halozyme Therapeutics | 9.14B |
| Kymera Therapeutics | 9.14B |
| Ionis Pharmaceuticals | 8.74B |
| Protagonist Therapeutics | 8.61B |
| Spyre Therapeutics | 8.57B |
| Praxis Precision Medicines | 8.50B |